Taking into account that only 8% of phase 1 clinical trials are usually successful, when the clinical trial to test the antifibrotic drug PXS-5505 in arthrofibrosis arises, would the probability of it being successful also be only 8%?

Is stem cell treatment effective in regenerating tissues affected by fibrosis, eliminating fibrosis, and also inflammation?